These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
349 related items for PubMed ID: 28888853
1. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K. Mol Genet Metab; 2017 Sep; 122(1-2):4-17. PubMed ID: 28888853 [Abstract] [Full Text] [Related]
9. Recovery of bone mineralization and quality during asfotase alfa treatment in an adult patient with infantile-onset hypophosphatasia. Rolvien T, Schmidt T, Schmidt FN, von Kroge S, Busse B, Amling M, Barvencik F. Bone; 2019 Oct 16; 127():67-74. PubMed ID: 31152801 [Abstract] [Full Text] [Related]
11. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Whyte MP, Simmons JH, Moseley S, Fujita KP, Bishop N, Salman NJ, Taylor J, Phillips D, McGinn M, McAlister WH. Lancet Diabetes Endocrinol; 2019 Feb 16; 7(2):93-105. PubMed ID: 30558909 [Abstract] [Full Text] [Related]
12. Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy. Bowden SA, Foster BL. Drug Des Devel Ther; 2018 Feb 16; 12():3147-3161. PubMed ID: 30288020 [Abstract] [Full Text] [Related]
13. Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia. Whyte MP, Rockman-Greenberg C, Ozono K, Riese R, Moseley S, Melian A, Thompson DD, Bishop N, Hofmann C. J Clin Endocrinol Metab; 2016 Jan 16; 101(1):334-42. PubMed ID: 26529632 [Abstract] [Full Text] [Related]
15. No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia. Whyte MP, McAlister WH, Mumm S, Bierhals AJ. Bone; 2019 May 16; 122():231-236. PubMed ID: 30825650 [Abstract] [Full Text] [Related]
16. Pharmacokinetics of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia. Pan WJ, Pradhan R, Pelto R, Seefried L. J Clin Pharmacol; 2021 Oct 16; 61(10):1334-1343. PubMed ID: 33822385 [Abstract] [Full Text] [Related]
17. Safety, pharmacokinetics, and pharmacodynamics of efzimfotase alfa, a second-generation enzyme replacement therapy: phase 1, dose-escalation study in adults with hypophosphatasia. Dahir KM, Shannon A, Dunn D, Voegtli W, Dong Q, Hasan J, Pradhan R, Pelto R, Pan WJ. J Bone Miner Res; 2024 Sep 26; 39(10):1412-1423. PubMed ID: 39135540 [Abstract] [Full Text] [Related]